Barcelona2,900 leukemia patients: conditioning intensity didn’t split survival.
In elderly acute myeloid leukemia, intense regimens risk toxicity death; light regimens risk relapse — a European marrow registry found 2-year survival equal.
Peripheral blood grafts outperformed bone marrow grafts; authors say the advantage warrants validation.
Sources: Nature